Zobrazeno 1 - 7
of 7
pro vyhledávání: '"L R Duska"'
Publikováno v:
Cancer. 89(7)
A reliable model for predicting the outcome of primary cytoreductive surgery may be a useful tool in the clinical management of patients with advanced epithelial ovarian carcinoma.Forty-one women with a preoperative computed tomographic (CT) scan of
Publikováno v:
The Journal of reproductive medicine. 44(8)
To review the incidence and outcome of clinically significant venous thromboembolism (VTE) following gynecologic surgery in a population receiving provider-specified prophylaxis.A computerized patient database was used to identify all patients diagno
Autor:
L R, Duska, R, Penson, J G, Supko, D M, Finkelstein, T, Makastorsis, J, Gallagher, K, Borden, A, Goodman, A F, Fuller, N, Nikrui, M V, Seiden
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(6)
A Phase I study of paclitaxel and doxorubicin administered as concurrent 96-h continuous i.v. infusion was performed to determine the maximum tolerated dose (MTD), principal toxicities, and pharmacokinetics of this combination in women with relapsed
Publikováno v:
Cancer. 85(12)
A retrospective review of women ageor = 40 years with epithelial ovarian carcinoma was undertaken to determine whether patient age and tumor grade are independent prognostic factors for survival, to investigate the survival rate for young women with
Autor:
N, Nikrui, L R, Duska
Publikováno v:
Surgical oncology clinics of North America. 7(2)
Primary fallopian tube carcinoma represents less than 1% of all gynecologic malignancies and is therefore one of the less common malignancies of the female genital tract. Fallopian tube carcinoma is rarely diagnosed preoperatively and is often mistak
Publikováno v:
Journal of Clinical Oncology. 26:16579-16579
16579 Background: Grade of tumor in early stage ovarian cancer has prognostic value and dictates post-operative adjuvant therapy. The purpose of this study is to determine if grade is of prognostic significance in serous cancer of the ovary in advanc
Publikováno v:
Journal of Lower Genital Tract Disease. 2:163